Chinese Journal of Cancer Research
Editor-in-Chief: Weicheng You
ISSN: 1000-9604
(print version)
ISSN: 1993-0631
(electronic version)
Journal no. 11670
Wei-cheng You, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Zheng E, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Yang Ke, Peking University Health Science Center, Beijing, China
Cheng-chao Shou, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Xiao-peng Zhang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jin Gu, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Yu-xin Yin, Peking University Health Science Center, Beijing, China
Zheng-gang Zhu, Shanghai Ruijin Hospital, Shanghai, China
David H Johnson, Vanderbilt University Medical Center, Nashville, USA
D David Dershaw, Sloan-Kettering Cancer Center, New York, USA
Guido Torzilli, Milan University, Milan, Italy
Han-Kwang Yang, Seoul National University, Seoul, Korea
Claussen Claus, Tuebingen University, Tübingen, Germany
Jack A Roth, MD Anderson Cancer Center, Houston, USA
Daniel Jaeck, Strasbourg University, Strasbourg, Germany
Wai Lun Law, Queen Mary Hospital, Hong Kong, China
zhong-xing Liao, MD Anderson Cancer Center, Houston, USA
Nam-kyu Kim, Yonsei University, Seoul, Korea
Pei-rong Yu, MD Anderson Cancer Center, Houston, USA
Jian Cao, State University of New York at Stony Brook, Stony Brook, USA
Wen-ming Cong, Second Military Medical University Eastern Hepatobiliary Hospital, Shanghai, China
Jing-yuan Fang, Shanghai Renji Hospital, Shanghai, China
Feng Feng, Peking Union Medical College Hospital, Beijing, China
Jian-hua Fu, Sun Yan-sen University Cancer Center, Guangzhou, China
Chuan-gang Fu, Shanghai Changhai Hospital, Shanghai, China
Guo-lan Gao, Beijing Aero-industry Center Hospital, Beijing, China
Hong-yan Guo, Peking University Third Hospital, Beijing, China
Jia-huai Han, Xiamen University, Xiamen, China
Jin-xiang Han, Medical Sciences Academy of Shandong Province, Jinan, China
Guo-fu Hu, Harvard University, Boston, USA
Wen-guo Jiang, Cardiff University, Cardiff, UK
Xiao-ping Kang, Peking University Health Science Center, Beijing, China
Ping Lan, Sun Yan-sen University Sixth Hospital, Guangzhou, China
Hui Li, Beijing Chaoyang Hospital, Beijing, China
Xiao-ping Li, Peking University People’s Hospital, Beijing, China
Ye-xiong Li, Chinese Academy of Medical Sciences Cancer Institute /Hospital, Beijing, China
Qin-ping Liao, Peking University First Hospital, Beijing, China
Dong-xin Lin, Chinese Academy of Medical Sciences Cancer Institute/Hospital, Beijing, China
Tong-yu Lin, Sun Yan-sen University Cancer Center, Guangzhou, China
Chieh-yu Liu, Taipei College of Nursing, Taipei, China
Shi-chun Lu, Beijing You’an Hospital, Beijing, China
Tai-xiang Lu, Sun Yan-sen University Cancer Center, Guangzhou, China
Shun Lu, Shanghai Thorax Hospital, Shanghai, China
Lin Ma, Beijing 301 Hospital, Beijing, China
Yan-qun Na, Beijing Shougang Hospital, Beijing, China
Jian-ji Pan, Cancer Hospital of Fujian Province, Fuzhou, China
Cheng Qian, Zhejiang Institute of Technology, Hangzhou, China
Jian-min Qian, Fudan University Huashan Hospital, Shanghai, China
Zhi-hai Qin, Chinese Academy of Sciences Biophysics Institute, Beijing, China
Zhi-min Shao, Fudan University Cancer Hospital, Shanghai, China
Yang Shentu, Shanghai Thorax Hospital, Shanghai, China
Hong-bing Shen, Nanjing Medical University Cancer Institute, Nanjing, China
Bin Shi, Beijing China-Japan Friendship Hospital, Beijing, China
Han-ping Shi, Sun Yan-sen University First Hospital, Guangzhou, China
Jun Wang, Peking University People’s Hospital, Beijing, China
Ming-rong Wang, Chinese Academy of Medical Sciences Cancer Institute, Beijing, China
Wei Wang, Capital Medical University School of Public Health, Beijing, China
Xiao-hua Wu, Fudan University Cancer Hospital, Shanghai, China
Dan Xie, Huanan State Key Lab. of Cancer, Guangzhou, China
Yan Xin, China Medical University Cancer Institute, Shenyang, China
Bing-he Xu, Chinese Academy of Medical Sciences Cancer Hospital, Beijing, China
An-gang Yang, Fourth Military Medical University, Xi’an, China
Li Zhang, Sun Yan-sen University Cancer Center, Guangzhou, China
Shu-ren Zhang, Chinese Academy of Medical Sciences Cancer Institute, Beijing, China
Ye Zhang, Chinese Academy of Medical Sciences Basic Medical Institute, Beijing, China
Xiu-yi Zhi, Beijing Xuanwu Hospital, Beijing, China
Yong-chang Zhou, Hong Kong University, Hong Kong, China
Wei-guo Zhu, Peking University Health Science Center, Beijing, China
Sheng-de Bao, Peking University First Hospital, Beijing, China
Qi-min Zhan, Chinese Academy of Medical Sciences Cancer Institute, Beijing, China
Shen-long Ye, Fudan University Liver Cancer Institute, Shanghai, China
You-yong Lü, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Da-jun Deng, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Lin Shen, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jun Ren, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jie Wang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jun Zhu, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jun Guo, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Ke-neng Chen, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Yue Yang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jia-fu Ji, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Chun-yi Hao, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Bao-cai Xing, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Zhi-wei Fang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Tao Ouyang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Yun-tao Xie, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Yu-nong Gao, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Xiang-qian Su, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jin-feng Li, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Guang-ying Zhu, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Shan-wen Zhang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Ren-jie Yang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Ping-ping Li, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Qing-yun Zhang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Kun Yan, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Wei-cheng Xue, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Nai-song Zhang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Bao-guo Liu, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Ji-chang Zhang, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
Jun Ma, Ha’erbin Hematology & Cancer Institute, Ha’erbin, China
Shu-kui Qin, Nanjing 81 Hospital, Nanjing, China
Tao Jiang, Beijing Tiantan Hospital, Beijing, China
Yuan-kai Shi, Chinese Academy of Medical Sciences Cancer Hospital, Beijing , China
Qing-yu Wei, MD Anderson Cancer Center, Houston, USA
Li Yan, Merck Co., North Wales, USA
Zhi-hua Liu, Chinese Academy of Medical Sciences Cancer Institute, Beijing, China
Cai-cun Zhou, Shanghai Tongji University Lung Disease Hospital, Shanghai, China
Roland M Schmid , Munich University, Munich, Germany
Read this Journal on Springerlink
For authors and editors
- 2012 Impact Factor
- 0,448
-
Aims and Scope
Aims and Scope
ClosePublishes high-quality original articles reporting new information on basic and clinical aspects of cancer research and related subjects. Scope includes cancer etiology and epidemiology, cancer prevention, cell and molecular biology, oncogenes, tumor pathology, cancer image and interventional diagnosis and therapy, surgical oncology, chemotherapy, radiotherapy and biotherapy, tumor markers.
- Submit Online
- Instructions for Authors (pdf, 16 kB)
-
English Language Editing
- Copyright Transfer Statement (pdf, 65 kB...
- Author Academy: Training for Authors
-
Copyright information
Copyright information
CloseSubmission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, review, or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as - tacitly or explicitly - by the responsible authorities at the institution where the work was carried out. The author warrants that his/her contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Chinese Anti-Cancer Association and Springer becomes effective if and when the article is accepted for publication. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Chinese Anti-Cancer Association and Springer. The copyright covers the exclusive right (for U.S. government employees: to the extent transferable) to reproduce and distribute the article, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or other reproductions of similar nature.
An author may self-archive an author-created version of his/her article on his/her own website and or in his/her institutional repository. He/she may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication. He/she may not use the publisher's PDF version, which is posted on www.springerlink.com, for the purpose of self-archiving or deposit. Furthermore, the author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The original publication is available at www.springerlink.com".
All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publishers. The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.While the advice and information in this journal is believed to be true and accurate at the date of its going to press, neither the authors, the editors, nor the publishers can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Special regulations for photocopies in the USA:Photocopies may be made for personal or in-house use beyond the limitations stipulated under Section 107 or 108 of U.S. Copyright Law, provided a fee is paid. All fees should be paid to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA, Tel.: +1-978-7508400, Fax: +1-978-6468600, http://www.copyright.com, stating the ISSN of the journal, the volume, and the first and last page numbers of each article copied. The copyright owner's consent does not include copying for general distribution, promotion, new works, or resale. In these cases, specific written permission must first be obtained from the publishers.
Springer-Verlag Berlin Heidelberg is a part of
Springer Science+Business Mediaspringer.com
Copyright
© Chinese Anti-Cancer Association and Springer-Verlag GmbH
Services for the Journal
Alerts for this journal
Get the table of contents of every new issue published in Chinese Journal of Cancer Research.
